A methodology to establish a database to study gene environment interactions for childhood asthma
暂无分享,去创建一个
Steve Cunningham | Alan Webb | Anil Mehta | Jon G Ayres | Gita Mehta | Sally McLeish | C. Palmer | T. Macfarlane | J. Ayres | S. Cunningham | S. Turner | Donna Corrigan | Tatiana V Macfarlane | U. Macfadyen | S. Mukhopadhyay | J. McCormick | G. Mehta | A. Mehta | Somnath Mukhopadhyay | Jonathan McCormick | Stephen W Turner | Colin N Palmer | Tim Adams | Krishnan Aniruddhan | Claire Bell | Donna Corrigan | Jason Cunningham | Andrew Duncan | Gerard Hunt | Richard Leece | Una MacFadyen | Andrew Mitra | Deborah Miller | Elizabeth Waxman | Slawomir Wojcik | Donald Macgregor | Andrew Duncan | D. Macgregor | Claire Bell | Tim Adams | Krishnan Aniruddhan | A. Mitra | S. Mcleish | J. Cunningham | Alan Webb | R. Leece | E. Waxman | Gerard Hunt | Deborah Miller | Slawomir Wojcik | C. Palmer | K. Aniruddhan | T. Adams
[1] M. Beauchesne,et al. Development and validation of database indexes of asthma severity and control , 2007, Thorax.
[2] E. Sims,et al. Potential benefits of the UK Cystic Fibrosis Database. , 2004, Journal of the Royal Society of Medicine.
[4] Anil Mehta,et al. Comparative analysis of Cystic Fibrosis Registry data from the UK with USA, France and Australasia. , 2005, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[5] A. Woodcock,et al. Endotoxin exposure, CD14, and allergic disease: an interaction between genes and the environment. , 2006, American journal of respiratory and critical care medicine.
[6] L. Palmer,et al. β2 adrenoceptor Arg16Gly polymorphism, airway responsiveness, lung function and asthma in infants and children , 2004 .
[7] J. Gustafson,et al. Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.
[8] S. Gabriel,et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. , 2004, Human molecular genetics.
[9] G. Morahan,et al. Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children , 2002, The Lancet.
[10] C. Feyerabend,et al. What determines levels of passive smoking in children with asthma? , 1997, Thorax.
[11] N. Heinrichs,et al. Parent Recruitment and Retention in a Universal Prevention Program for Child Behavior and Emotional Problems: Barriers to Research and Program Participation , 2005, Prevention Science.
[12] G. Russell,et al. Respiratory symptoms and atopy in children in Aberdeen: questionnaire studies of a defined school population repeated over 35 years , 2004, BMJ : British Medical Journal.
[13] E. Mutius. Gene-environment interactions in asthma , 2009 .
[14] J. Spinelli,et al. Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity. , 2000, The Journal of allergy and clinical immunology.
[15] S. Ogston,et al. Asians with cystic fibrosis in the UK have worse disease outcomes than clinic matched white homozygous delta F508 controls. , 2005, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[16] D. Mannino,et al. Involuntary smoking and asthma severity in children: data from the Third National Health and Nutrition Examination Survey. , 2002, Chest.
[17] J. Ayres,et al. Household chemicals, persistent wheezing and lung function: effect modification by atopy? , 2008, European Respiratory Journal.
[18] J. McCormick,et al. Demographics of the UK cystic fibrosis population: implications for neonatal screening , 2002, European Journal of Human Genetics.
[19] Fernando Holguin,et al. Asthma Phenotypes, Risk Factors, and Measures of Severity in a National Sample of US Children , 2005, Pediatrics.
[20] N Franklin Adkinson,et al. Long-term effects of budesonide or nedocromil in children with asthma. , 2000, The New England journal of medicine.
[21] I. Romieu,et al. Antioxidant supplementation and lung functions among children with asthma exposed to high levels of air pollutants. , 2002, American journal of respiratory and critical care medicine.
[22] W D Flanders,et al. Sample size requirements in case-only designs to detect gene-environment interaction. , 1997, American journal of epidemiology.
[23] L. Leng,et al. Role for macrophage migration inhibitory factor in asthma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[24] T H Beaty,et al. Minimum sample size estimation to detect gene-environment interaction in case-control designs. , 1994, American journal of epidemiology.
[25] B. Lipworth,et al. Arginine-16 β2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol , 2006, Thorax.
[26] Colin N A Palmer,et al. Filaggrin null mutations are associated with increased asthma severity in children and young adults. , 2007, The Journal of allergy and clinical immunology.
[27] G. Heldt,et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. , 2005, The Journal of allergy and clinical immunology.
[28] J. Tonascia,et al. Budesonide and nedocromil did not improve lung function in children with asthma The Childhood Asthma Management Program Research Group. Long›term effects of budesonide or nedocromil in children , 2001 .
[29] S. Stanojevic,et al. Reference ranges for spirometry across all ages: a new approach. , 2008, American journal of respiratory and critical care medicine.
[30] E. Sims,et al. Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes. , 2005, Diabetes care.
[31] S. Weiss,et al. Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways. , 2005, Human molecular genetics.
[32] S. Turner,et al. Validation of a hand‐held exhaled nitric oxide analyzer for use in children , 2006, Pediatric pulmonology.
[33] P. Helms,et al. Spirometry in 5‐year‐olds—validation of current guidelines and the relation with asthma , 2007, Pediatric pulmonology.
[34] S. Weiss,et al. TBX21: A functional variant predicts improvement in asthma with the use of inhaled corticosteroids , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[35] P. Phelan,et al. The Melbourne Asthma Study: 1964-1999. , 2002, The Journal of allergy and clinical immunology.
[36] D. Postma,et al. Childhood factors associated with asthma remission after 30 year follow up , 2004, Thorax.
[37] C. Palmer,et al. A polymorphism controlling ORMDL3 expression is associated with asthma that is poorly controlled by current medications. , 2008, The Journal of allergy and clinical immunology.
[38] L. Palmer,et al. The relationship between infant airway function, childhood airway responsiveness, and asthma. , 2004, American journal of respiratory and critical care medicine.
[39] J. Hankinson,et al. Standardisation of spirometry , 2005, European Respiratory Journal.
[40] E. Robles,et al. Relationship of body mass index with asthma indicators in head start children. , 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[41] F COLYER. Asymmetry of the Dental Arch in a Toque Monkey (MacAca Sinica) , 1951, Proceedings of the Royal Society of Medicine.
[42] E. Silverman,et al. CD14 tobacco gene-environment interaction modifies asthma severity and immunoglobulin E levels in Latinos with asthma. , 2005, American journal of respiratory and critical care medicine.
[43] M J Khoury,et al. Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. , 2001, American journal of epidemiology.
[44] J. Pepys. Skin tests for immediate, type I, allergic reactions. , 1972, Proceedings of the Royal Society of Medicine.
[45] S. London,et al. Parental Smoking Modifies the Relation between Genetic Variation in Tumor Necrosis Factor-α (TNF) and Childhood Asthma , 2007, Environmental health perspectives.